Sodium oxybate improves excessive daytime sleepiness in narcolepsy

Sleep

Volumn 29, Issue 7, 2006, Pages 939-946

  Black, Jed ^a   Houghton, William C ^b  

^a STANFORD UNIVERSITY   (United States)

^b JAZZ PHARMACEUTICALS   (United States)

Author keywords

Excessive daytime sleepiness; Gamma hydroxybutyrate; Modafinil; Narcolepsy; Polysomnography; Sodium oxybate

Indexed keywords

ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; GLUCOSE; LACTATE DEHYDROGENASE; MODAFINIL; OXYBATE SODIUM; PLACEBO;

ABDOMINAL PAIN; ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAYTIME SOMNOLENCE; DISEASE ASSOCIATION; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG POTENTIATION; EPWORTH SLEEPINESS SCALE; FEMALE; FEVER; GLUCOSE BLOOD LEVEL; HEADACHE; HEART PALPITATION; HUMAN; HYPERTENSION; HYPERVENTILATION; HYPOTENSION; LACTATE DEHYDROGENASE BLOOD LEVEL; LATENT PERIOD; MAINTENANCE WAKEFULNESS TEST; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; NARCOLEPSY; NAUSEA; PARESTHESIA; POLYSOMNOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RHINOPHARYNGITIS; SCORING SYSTEM; SIDE EFFECT; SOMNOLENCE; TREATMENT OUTCOME; TREMOR; UPPER RESPIRATORY TRACT INFECTION; VOMITING;

EID: 33745728203     PISSN: 01618105     EISSN: None     Source Type: Journal    
DOI: 10.1093/sleep/29.7.939     Document Type: Article

References (15)

1. Overeem S, Mignot E, van Dijk JG, Lammers GJ. Narcolepsy: clinical features, new pathophysiologic insights and future perspectives. J Clin Neurophysiol 2001;18:78-105.
2. Littner M, Johnson SF, McCall WV, et al. Practice parameters for the treatment of narcolepsy: an update for 2000. Sleep 2001;24:451-66.
3. Mitler MM, Erman M, Hajdukovic R. The treatment of excessive somnolence with stimulant drugs. Sleep 1993;16:203-6.
4. Hublin C. Narcolepsy. Current drug treatment options. CNS Drugs 1996;5:426-36.
5. US Modafmil in Narcolepsy Multicenter Study Group. Randomized trial of modafmil for the treatment of pathological somnolence in narcolepsy. Ann Neurol 1998;43:88-97.
6. US Xyrem® Multicenter Study Group. A randomized, double blind, placebo-controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy. Sleep 2002;25:42-9.
7. US Xyrem® Multicenter Study Group. Sodium oxybate demonstrates long-term efficacy for the treatment of cataplexy in patients with narcolepsy. Sleep Med 2004;5:119-23.
8. US Xyrem® Multicenter Study Group. A 12-month, open-label, multi-center extension trial of orally administered sodium oxybate for the treatment of narcolepsy. Sleep 2003;26:31-5.
9. Broughton R, Mamelak M. The treatment of narcolepsy-cataplexy with nocturnal gamma hydroxybutyrate. Can J Neurol Sci 1979;6:1-6.
10. Scharf M, Brown D, Woods M, Brown L, Hirschowitz J. The effects and effectiveness of γ-hydroxybutyrate in patients with narcolepsy. J Clin Psychiatry 1985;46:222-5.
11. Lammers GJ, Arends J, Declerck AC, Ferrari MD, Schouwink G, Troost J. Gammahydroxybutyrate and narcolepsy: a double- blind placebo-controlled study. Sleep 1993;16:216-20.
12. Mamelak M, Black J, Montplaisir J, Ristanovic R. A pilot study on the effects of sodium oxybate on sleep architecture and daytime alertness in narcolepsy. Sleep 2004;27:1327-34.
13. Xyrem® International Study Group. A double-blind, placebo-controlled study demonstrates sodium oxybate is effective for the treatment of excessive daytime sleepiness in narcolepsy. J Clin Sleep Med 2006:In Press.
14. Doghramji K, Mitler MM, Sangal RB, et al. A normative study of the maintenance of wakefulness test (MWT). Electroencephalogr Clin Neurophysiol 1997;103:554-62.
15. Johns MW. A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep 1991;14:540-5.